Prokidney Corp Stock Buy Hold or Sell Recommendation
| PROK Stock | USD 1.67 0.12 6.70% |
Given the investment horizon of 90 days and complete risk avoidance on your part, our recommendation regarding ProKidney Corp is 'Strong Sell'. The recommendation algorithm takes into account all of ProKidney Corp's available fundamental, technical, and predictive indicators you will find on this site.
Check out ProKidney Corp Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide. Note, we conduct extensive research on individual companies such as ProKidney and provide practical buy, sell, or hold advice based on investors' constraints. ProKidney Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
ProKidney |
Execute ProKidney Corp Buy or Sell Advice
The ProKidney recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on ProKidney Corp. Macroaxis does not own or have any residual interests in ProKidney Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute ProKidney Corp's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Very Weak | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
ProKidney Corp Trading Alerts and Improvement Suggestions
| ProKidney Corp had very high historical volatility over the last 90 days | |
| ProKidney Corp may become a speculative penny stock | |
| ProKidney Corp has high likelihood to experience some financial distress in the next 2 years | |
| ProKidney Corp currently holds 4.41 M in liabilities with Debt to Equity (D/E) ratio of 5.66, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. ProKidney Corp has a current ratio of 0.73, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about ProKidney Corp's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (135.45 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ProKidney Corp currently holds about 21.88 M in cash with (90.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36. | |
| ProKidney Corp has a very weak financial position based on the latest SEC disclosures | |
| Roughly 27.0% of ProKidney Corp outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: ProKidney to Present at the 43rd Annual J.P. Morgan Healthcare Conference |
ProKidney Corp Returns Distribution Density
The distribution of ProKidney Corp's historical returns is an attempt to chart the uncertainty of ProKidney Corp's future price movements. The chart of the probability distribution of ProKidney Corp daily returns describes the distribution of returns around its average expected value. We use ProKidney Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of ProKidney Corp returns is essential to provide solid investment advice for ProKidney Corp.
| Mean Return | 0.25 | Value At Risk | -8.92 | Potential Upside | 8.43 | Standard Deviation | 6.25 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of ProKidney Corp historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
ProKidney Stock Institutional Investors
| Shares | Nuveen Asset Management, Llc | 2024-09-30 | 227.2 K | Bank Of New York Mellon Corp | 2024-09-30 | 190.5 K | Goldman Sachs Group Inc | 2024-09-30 | 188.1 K | Amundi | 2024-09-30 | 156 K | Barclays Plc | 2024-09-30 | 146.3 K | Alps Advisors Inc | 2024-09-30 | 97.4 K | Rhumbline Advisers | 2024-09-30 | 90.4 K | Alliancebernstein L.p. | 2024-09-30 | 84.2 K | Citigroup Inc | 2024-09-30 | 75.2 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 14.3 M | Suvretta Capital Management, Llc | 2024-09-30 | 12.3 M |
ProKidney Corp Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (10.6M) | 16.0M | 469.7M | (429.6M) | (386.6M) | (367.3M) | |
| Free Cash Flow | (30.6M) | (55.5M) | (78.9M) | (124.3M) | (111.8M) | (106.2M) | |
| Depreciation | 964K | 2.0M | 3.0M | 3.2M | 3.6M | 2.0M | |
| Other Non Cash Items | 604.0 | 4.7M | 40.4M | (5.3M) | (6.1M) | (5.8M) | |
| Capital Expenditures | 5.5M | 5.2M | 1.8M | 34.2M | 39.3M | 41.3M | |
| Net Income | (26.7M) | (55.1M) | (148.1M) | (135.4M) | (121.9M) | (115.8M) | |
| End Period Cash Flow | 4.6M | 20.6M | 490.3M | 60.6M | 69.7M | 126.7M |
ProKidney Corp Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to ProKidney Corp or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that ProKidney Corp's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a ProKidney stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.22 | |
β | Beta against Dow Jones | 0.57 | |
σ | Overall volatility | 6.29 | |
Ir | Information ratio | 0.03 |
ProKidney Corp Volatility Alert
ProKidney Corp is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure ProKidney Corp's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact ProKidney Corp's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.ProKidney Corp Fundamentals Vs Peers
Comparing ProKidney Corp's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze ProKidney Corp's direct or indirect competition across all of the common fundamentals between ProKidney Corp and the related equities. This way, we can detect undervalued stocks with similar characteristics as ProKidney Corp or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of ProKidney Corp's fundamental indicators could also be used in its relative valuation, which is a method of valuing ProKidney Corp by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare ProKidney Corp to competition |
| Fundamentals | ProKidney Corp | Peer Average |
| Return On Equity | -0.31 | -0.31 |
| Return On Asset | -0.2 | -0.14 |
| Current Valuation | (171.31 M) | 16.62 B |
| Shares Outstanding | 127.97 M | 571.82 M |
| Shares Owned By Insiders | 27.43 % | 10.09 % |
| Shares Owned By Institutions | 43.81 % | 39.21 % |
| Number Of Shares Shorted | 10.65 M | 4.71 M |
| Price To Book | 91.32 X | 9.51 X |
| EBITDA | (147.67 M) | 3.9 B |
| Net Income | (135.45 M) | 570.98 M |
| Cash And Equivalents | 21.88 M | 2.7 B |
| Cash Per Share | 0.36 X | 5.01 X |
| Total Debt | 4.41 M | 5.32 B |
| Debt To Equity | 5.66 % | 48.70 % |
| Current Ratio | 0.74 X | 2.16 X |
| Book Value Per Share | (7.66) X | 1.93 K |
| Cash Flow From Operations | (90.07 M) | 971.22 M |
| Short Ratio | 22.54 X | 4.00 X |
| Earnings Per Share | (0.54) X | 3.12 X |
| Target Price | 4.67 | |
| Number Of Employees | 163 | 18.84 K |
| Beta | 1.31 | -0.15 |
| Market Capitalization | 1.81 B | 19.03 B |
| Total Asset | 420.55 M | 29.47 B |
| Retained Earnings | (1.14 B) | 9.33 B |
| Working Capital | 349.11 M | 1.48 B |
| Net Asset | 420.55 M |
Note: Acquisition by Fox Jennifer A. of 42515 shares of ProKidney Corp at 10.92 subject to Rule 16b-3 [view details]
ProKidney Corp Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as ProKidney . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 27124.03 | |||
| Daily Balance Of Power | (0.86) | |||
| Rate Of Daily Change | 0.93 | |||
| Day Median Price | 1.74 | |||
| Day Typical Price | 1.72 | |||
| Price Action Indicator | (0.13) | |||
| Period Momentum Indicator | (0.12) |
About ProKidney Corp Buy or Sell Advice
When is the right time to buy or sell ProKidney Corp? Buying financial instruments such as ProKidney Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having ProKidney Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Pharmaceutical Products Thematic Idea Now
Pharmaceutical Products
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Pharmaceutical Products theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Pharmaceutical Products Theme or any other thematic opportunities.
| View All Next | Launch |
Check out ProKidney Corp Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. If investors know ProKidney will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProKidney Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ProKidney Corp is measured differently than its book value, which is the value of ProKidney that is recorded on the company's balance sheet. Investors also form their own opinion of ProKidney Corp's value that differs from its market value or its book value, called intrinsic value, which is ProKidney Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProKidney Corp's market value can be influenced by many factors that don't directly affect ProKidney Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProKidney Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProKidney Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProKidney Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.